Efficacy of Gaultheria procumbens 12C in reducing the triglyceride level in hypertriglyceridemia
Phase 3
- Conditions
- Health Condition 1: E785- Hyperlipidemia, unspecified
- Registration Number
- CTRI/2022/10/046608
- Lead Sponsor
- DR KANISHKA GANDHI
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient from 20-65 years of age irrespective of the gender.
Patient with triglycerides level in between 150-500 mg/dl
Patient who are not under conventional treatment for
hypercholesteremia.
Exclusion Criteria
Evidence of trigylceridemia associated with pancreatitis.
Patient with any complicated systemic illness.
Immunocompromised patients.
Pregnant and lactating mothers.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To determine the change in reducing the level of triglycerides in <br/ ><br>hypertriglyceridemia after administration of Gaultheria <br/ ><br>procumbens 12C.Timepoint: 6 months enrollment and 6 months follow up
- Secondary Outcome Measures
Name Time Method To find out the changes in the lipid profile after Gaultheria <br/ ><br>procumbens. <br/ ><br>ii) To find out the changes in the values of liver function test <br/ ><br>after Gaultheria procumbens.Timepoint: 6 months enrollment and 6 months follow up